| Product/ Candidate |
Therapeutic Area |
Stage
Discovery
POC
FDA |
Academic |
Commercial |
|---|---|---|---|---|
 |
Substance Use Disorder |
 |
 |
|
 |
Opioid Use Disorder |
|
|
|
| PEAR-003 | Insomnia/ Depression |
 |
||
| PEAR-004 | Schizophrenia (Pos Sx) |
 |
||
| DISCOVERY | Cognition |
|
||
| DISCOVERY | Epilepsy | |||
| reCALL™ | PTSD |  |
||
| PEAR-007 | Pain | |||
| DISCOVERY | Movement Disorders | |||
| PEAR-006 | Multiple Sclerosis | |
||
| DISCOVERY | Migraine | |||
| DISCOVERY | Autism Spectrum Disorder |
|
||
| DISCOVERY | Oncology, Inflammation, CV, GI, Respiratory | |||
